Nine-valent vaccine is often referred to as the nine-valent human papillomavirus vaccine, which is primarily used to prevent the development of tumors associated with high-risk types of human papillomavirus. The nine-valent human papillomavirus (HPV) vaccine is primarily used to prevent nine high-risk HPV genotypes (types 6, 11, 16, 18, 31, 33, 45, 52, and 58). High-risk HPV infections can cause cervical lesions and the development of tumors of the cervix, vagina, vulva, anus, penis, and mouth. The Septavalent HPV vaccine reduces the rate of HPV infection and the incidence of HPV-related cancers. Adverse reactions to the Septavalent vaccine include pain, swelling, and erythema at the injection site. It is recommended to seek medical attention for any need or discomfort.